Journal
NEURON
Volume 110, Issue 10, Pages 1671-+Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2022.02.011
Keywords
-
Categories
Funding
- Target ALS
- Bristol Myers Squibb
- Harvard Stem Cell Institute
- Healey Scholars Fellowship
- NIH [5K99AG057808-02]
- Tom Kirchhoff Family Postdoctoral Fellowship from Project ALS
- Harvard Center for Biological Imaging
Ask authors/readers for more resources
This study found that disrupting a single TDP43-regulated RNA gene is sufficient to cause substantial motor dysfunction, indicating that disruption of TDP43 function likely contributes to ALS.
Amyotrophic lateral sclerosis (ALS) is characterized by motor neuron degeneration accompanied by aberrant accumulation and loss of function of the RNA-binding protein TDP43. Thus far, it remains unresolved to what extent TDP43 loss of function directly contributes to motor system dysfunction. Here, we employed gene editing to find whether the mouse ortholog of the TDP43-regulated gene STMN2 has an important function in maintaining the motor system. Both mosaic founders and homozygous loss-of-function Stmn2 mice exhibited neuromuscular junction denervation and fragmentation, resulting in muscle atrophy and impaired motor behavior, accompanied by an imbalance in neuronal microtubule dynamics in the spinal cord. The introduction of human STMN2 through BAC transgenesis was sufficient to rescue the motor phenotypes observed in Stmn2 mutant mice. Collectively, our results demonstrate that disrupting the ortholog of a single TDP43-regulated RNA is sufficient to cause substantial motor dysfunction, indicating that disruption of TDP43 function is likely a contributor to ALS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available